Ultralife Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Ultralife Corporation (ULBI) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income6.417.17-0.12-0.235.23
Depreciation & Amortization4.163.914.463.542.94
Deferred Income Tax1.231.30-0.96-0.150.00
Stock Based Compensation0.700.530.780.670.94
Change in Working Capital3.89-11.04-5.450.3912.67
Change in Accounts Receivable7.60-3.89-7.884.429.21
Change in Inventory-0.11-0.94-8.75-1.301.80
Change in Accounts Payable0.22-2.9710.09-2.711.65
Change in Other Working Capital0.25-3.100.040.06-0.13
Other Operating Activities0.251.300.04-0.14-0.11
Net Cash from Operating Activities16.641.93-1.264.3321.72
Investing Activities
Capital Expenditures-1.93-2.55-1.68-2.81-3.10
Acquisitions-48.020.000.00-23.520.00
Net Cash from Investing Activities-49.95-2.55-1.68-26.33-2.98
Financing Activities
Debt Repayment-25.75-3.00-2.83-1.47-15.84
Common Stock Issued2.001.250.120.400.24
Common Stock Repurchased0.00-0.01-0.02-0.15-0.09
Other Financing Activities-1.39-0.01-0.12-0.110.00
Net Cash from Financing Activities29.865.490.5219.64-15.69
Summary
Effect of Forex Changes on Cash0.03-0.30-0.280.130.00
Net Change in Cash-3.464.57-2.42-2.243.25
Cash at Beginning of Period10.285.718.4110.650.00
Cash at End of Period6.8510.285.718.410.00
Free Cash Flow14.70-0.62-2.941.5118.62
Supplemental Disclosures
Interest Paid1.861.960.930.140.38
Income Taxes Paid0.720.770.350.320.26